Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Chelsea Therapeutics International Ltd.    

CHELSEA THERAPEUTICS INTERNATIONAL LTD.
Mes dernières consult.
Most popular
  Report  
 SummaryNewsCalendarCompanyFinancials 
Company
Chelsea Therapeutics International Ltd. acquires, develops and commercializes innovative products for the treatment of a variety of human diseases.The company was founded by Simon C. Pedder on June 17, 2005 and is headquartered in Charlotte, NC. 
More about the company
Latest news on CHELSEA THERAPEUTICS INTER
2014Chelsea Therapeutics Presents Efficacy and Safety Data for NORTHERA at Intern..
GL
2014CHELSEA THERAPEUTICS : Shareholder Alert: Former SEC Attorney Willie Briscoe and..
BU
2014CHELSEA THERAPEUTICS : SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investi..
BU
2014CHELSEA THERAPEUTICS : INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investiga..
BU
2014CHELSEA THERAPEUTICS : Newman Ferrara LLP : Announces Investigation of Chelsea T..
BU
2014CHELSEA THERAPEUTICS : SHAREHOLDER ALERT: Brower Piven Announces the Investigati..
BU
2014CHELSEA THERAPEUTICS : Law Firm Kirby McInerney LLP Investigating Potential Clai..
BU
2014CHELSEA THERAPEUTICS : SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Inves..
BU
2014CHELSEA THERAPEUTICS : INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investiga..
BU
2014Chelsea Therapeutics Joins NORD in Promoting Awareness for Rare Disease Day
GL
More news
Sector news : Bio Therapeutic Drugs
07/19Novartis, MorphoSys and Galapagos Shares Rise on News of Deal
DJ
07/09LONZA : restates 2017 figures after changing accounting standard
RE
07/03Sanofi beefs up diabetes pipeline to retrieve success
RE
06/29European stocks shrug off trade worries with quarterly gain
RE
06/29GILEAD SCIENCES : Rival Novartis, Gilead CAR-T therapies win European panel reco..
RE
More sector news : Bio Therapeutic Drugs
Income Statement Evolution
Managers
NameTitle
Staffan Schüberg President & Director
Julie Hakim Secretary, Treasurer & Director
Sector and Competitors
1st jan.Capitalization (M$)
CHELSEA THERAPEUTICS INTERNATIONAL LTD.0
GILEAD SCIENCES7.65%100 276
VERTEX PHARMACEUTICALS20.87%46 157
REGENERON PHARMACEUTICALS-2.65%38 776
GENMAB9.33%10 846
NEUROCRINE BIOSCIENCES, INC.33.79%9 279